Standout Papers

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma 2007 2026 2013 2019 988
  1. Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma (2012)
    Aleksandar Sekulić, Michael R. Migden et al. New England Journal of Medicine
  2. Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma (2009)
    Daniel D. Von Hoff, Patricia LoRusso et al. New England Journal of Medicine
  3. Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer (2007)
    Stephen A. Cannistra, Ursula A. Matulonis et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 27 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

Single-cell transcriptional diversity is a hallmark of developmental potential
2020 StandoutScience
Creation of bladder assembloids mimicking tissue regeneration and cancer
2020 StandoutNature
3 intermediate papers

Works of Howard Mackey being referenced

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
2012 Standout

Author Peers

Author Last Decade Papers Cites
Howard Mackey 1878 877 19 675 21 2.7k
Stephen Lade 1092 889 44 332 44 3.1k
Susan Shanley 1372 1057 32 83 34 2.3k
B. J. Kerns 872 1154 9 118 25 2.2k
David Sarrió 2604 2001 69 148 37 4.4k
S Hirohashi 1868 1709 54 351 28 3.6k
Hadi Yaziji 1082 1758 192 131 41 3.5k
Josina C. Reddy 2520 800 12 781 18 3.0k
M. A. Tucker 1079 1407 51 126 18 2.3k
Shoji Kodama 466 790 13 255 39 2.5k
Lorenza Pecciarini 827 846 34 151 42 2.1k

All Works

Loading papers...

Rankless by CCL
2026